Your browser doesn't support javascript.
loading
Response to letter entitled: 'Re: Hematological immune related adverse events after treatment with immune checkpoint inhibitors'.
Heinzerling, Lucie; La Rosée, Paul; Gutzmer, Ralf; Kramer, Rafaela; Keller-Stanislawski, Brigitte; Zierold, Sarah; Mentzer, Dirk.
  • Heinzerling L; Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany; Department of Dermatology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany. Electronic address: lucie.heinzerling@med.uni-muenchen.de.
  • La Rosée P; II. Med. Klinik, Onkologie, Hämatologie, Immunologie, Infektiologie, Palliativmedizin Schwarzwald-Baar-Klinikum, Villingen-Schwenningen, Germany.
  • Gutzmer R; Department of Dermatology, Mühlenkreiskliniken AöR, Ruhr University Bochum Campus, Minden, Germany.
  • Kramer R; Department of Dermatology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Keller-Stanislawski B; Paul-Ehrlich Institut, Langen, Germany.
  • Zierold S; Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.
  • Mentzer D; Paul-Ehrlich Institut, Langen, Germany.
Eur J Cancer ; 153: 272-273, 2021 08.
Article en En | MEDLINE | ID: mdl-34154880
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidores de Puntos de Control Inmunológico Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidores de Puntos de Control Inmunológico Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article